Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
Add more filters










Database
Language
Publication year range
1.
Sci Transl Med ; 11(488)2019 04 17.
Article in English | MEDLINE | ID: mdl-30996083

ABSTRACT

Filamentous bacteriophage (Pf phage) contribute to the virulence of Pseudomonas aeruginosa infections in animal models, but their relevance to human disease is unclear. We sought to interrogate the prevalence and clinical relevance of Pf phage in patients with cystic fibrosis (CF) using sputum samples from two well-characterized patient cohorts. Bacterial genomic analysis in a Danish longitudinal cohort of 34 patients with CF revealed that 26.5% (n = 9) were consistently Pf phage positive. In the second cohort, a prospective cross-sectional cohort of 58 patients with CF at Stanford, sputum qPCR analysis showed that 36.2% (n = 21) of patients were Pf phage positive. In both cohorts, patients positive for Pf phage were older, and in the Stanford CF cohort, patients positive for Pf phage were more likely to have chronic P. aeruginosa infection and had greater declines in pulmonary function during exacerbations than patients negative for Pf phage presence in the sputum. Last, P. aeruginosa strains carrying Pf phage exhibited increased resistance to antipseudomonal antibiotics. Mechanistically, in vitro analysis showed that Pf phage sequesters these same antibiotics, suggesting that this mechanism may thereby contribute to the selection of antibiotic resistance over time. These data provide evidence that Pf phage may contribute to clinical outcomes in P. aeruginosa infection in CF.


Subject(s)
Cystic Fibrosis/microbiology , Lung/microbiology , Pseudomonas/pathogenicity , Animals , Anti-Bacterial Agents/pharmacology , Cross-Sectional Studies , Drug Resistance, Microbial/genetics , Drug Resistance, Microbial/physiology , Humans , Inovirus , Microbial Sensitivity Tests , Prospective Studies
2.
Science ; 363(6434)2019 03 29.
Article in English | MEDLINE | ID: mdl-30923196

ABSTRACT

Bacteriophage are abundant at sites of bacterial infection, but their effects on mammalian hosts are unclear. We have identified pathogenic roles for filamentous Pf bacteriophage produced by Pseudomonas aeruginosa (Pa) in suppression of immunity against bacterial infection. Pf promote Pa wound infection in mice and are associated with chronic human Pa wound infections. Murine and human leukocytes endocytose Pf, and internalization of this single-stranded DNA virus results in phage RNA production. This triggers Toll-like receptor 3 (TLR3)- and TIR domain-containing adapter-inducing interferon-ß (TRIF)-dependent type I interferon production, inhibition of tumor necrosis factor (TNF), and the suppression of phagocytosis. Conversely, immunization of mice against Pf prevents Pa wound infection. Thus, Pf triggers maladaptive innate viral pattern-recognition responses, which impair bacterial clearance. Vaccination against phage virions represents a potential strategy to prevent bacterial infection.


Subject(s)
Immune Tolerance , Phagocytosis/immunology , Pseudomonas Infections/immunology , Pseudomonas Phages/physiology , Pseudomonas aeruginosa/pathogenicity , Pseudomonas aeruginosa/virology , Wound Infection/immunology , Adaptor Proteins, Vesicular Transport/genetics , Adaptor Proteins, Vesicular Transport/immunology , Animals , Antibodies, Viral/immunology , Humans , Interferons/immunology , Male , Mice , Mice, Inbred C57BL , Mice, Mutant Strains , Pseudomonas Phages/immunology , Toll-Like Receptor 3/genetics , Toll-Like Receptor 3/immunology , Tumor Necrosis Factor-alpha/metabolism
3.
Cell Rep ; 21(6): 1442-1451, 2017 Nov 07.
Article in English | MEDLINE | ID: mdl-29117551

ABSTRACT

Increasing evidence implies an extensive and universal interaction between the immune system and the nervous system. Previous studies showed that OCTR-1, a neuronal G-protein-coupled receptor (GPCR) analogous to human norepinephrine receptors, functions in sensory neurons to control the gene expression of both microbial killing pathways and the unfolded protein response (UPR) in Caenorhabditis elegans. Here, we found that OCTR-1-expressing neurons, ASH, are involved in controlling innate immune pathways. In contrast, another group of OCTR-1-expressing neurons, ASI, was shown to promote pathogen avoidance behavior. We also identified neuropeptide NLP-20 and AIA interneurons, which are responsible for the integration of conflicting cues and behaviors, as downstream components of the ASH/ASI neural circuit. These findings provide insights into a neuronal network involved in regulating pathogen defense mechanisms in C. elegans and might have broad implications for the strategies utilized by metazoans to balance the energy-costly immune activation and behavioral response.


Subject(s)
Caenorhabditis elegans Proteins/metabolism , Immunity, Innate , Neuropeptides/metabolism , Pseudomonas aeruginosa/pathogenicity , Sensory Receptor Cells/metabolism , Animals , Behavior, Animal , Caenorhabditis elegans/immunology , Caenorhabditis elegans/metabolism , Caenorhabditis elegans Proteins/genetics , Microscopy, Fluorescence , Mitogen-Activated Protein Kinases/metabolism , Mutagenesis , Neuropeptides/genetics , Receptors, G-Protein-Coupled/genetics , Receptors, G-Protein-Coupled/metabolism , Signal Transduction , p38 Mitogen-Activated Protein Kinases/metabolism
4.
DNA Repair (Amst) ; 52: 31-48, 2017 04.
Article in English | MEDLINE | ID: mdl-28242054

ABSTRACT

Mercury toxicity mechanisms have the potential to induce DNA damage and disrupt cellular processes, like mitochondrial function. Proper mitochondrial function is important for cellular bioenergetics and immune signaling and function. Reported impacts of mercury on the nuclear genome (nDNA) are conflicting and inconclusive, and mitochondrial DNA (mtDNA) impacts are relatively unknown. In this study, we assessed genotoxic (mtDNA and nDNA), metabolic, and innate immune impacts of inorganic and organic mercury exposure in Caenorhabditis elegans. Genotoxic outcomes measured included DNA damage, DNA damage repair (nucleotide excision repair, NER; base excision repair, BER), and genomic copy number following MeHg and HgCl2 exposure alone and in combination with known DNA damage-inducing agents ultraviolet C radiation (UVC) and hydrogen peroxide (H2O2), which cause bulky DNA lesions and oxidative DNA damage, respectively. Following exposure to both MeHg and HgCl2, low-level DNA damage (∼0.25 lesions/10kb mtDNA and nDNA) was observed. Unexpectedly, a higher MeHg concentration reduced damage in both genomes compared to controls. However, this observation was likely the result of developmental delay. In co-exposure treatments, both mercury compounds increased initial DNA damage (mtDNA and nDNA) in combination with H2O2 exposure, but had no impact in combination with UVC exposure. Mercury exposure both increased and decreased DNA damage removal via BER. DNA repair after H2O2 exposure in mercury-exposed nematodes resulted in damage levels lower than measured in controls. Impacts to NER were not detected. mtDNA copy number was significantly decreased in the MeHg-UVC and MeHg-H2O2 co-exposure treatments. Mercury exposure had metabolic impacts (steady-state ATP levels) that differed between the compounds; HgCl2 exposure decreased these levels, while MeHg slightly increased levels or had no impact. Both mercury species reduced mRNA levels for immune signaling-related genes, but had mild or no effects on survival on pathogenic bacteria. Overall, mercury exposure disrupted mitochondrial endpoints in a mercury-compound dependent fashion.


Subject(s)
Caenorhabditis elegans/drug effects , DNA Damage , DNA Repair , Mercury/toxicity , Methylmercury Compounds/toxicity , Mitochondria/drug effects , Animals , Caenorhabditis elegans/metabolism , Caenorhabditis elegans/radiation effects , Cell Nucleus/drug effects , Cell Nucleus/genetics , Cell Nucleus/radiation effects , DNA, Helminth/drug effects , DNA, Helminth/physiology , DNA, Helminth/radiation effects , Homeostasis , Hydrogen Peroxide/toxicity , Kinetics , Mitochondria/genetics , Mitochondria/radiation effects , Ultraviolet Rays
6.
Curr Biol ; 26(17): 2329-34, 2016 09 12.
Article in English | MEDLINE | ID: mdl-27524480

ABSTRACT

The innate immune system is the front line of host defense against microbial infections, but its rapid and uncontrolled activation elicits microbicidal mechanisms that have deleterious effects [1, 2]. Increasing evidence indicates that the metazoan nervous system, which responds to stimuli originating from both the internal and the external environment, functions as a modulatory apparatus that controls not only microbial killing pathways but also cellular homeostatic mechanisms [3-5]. Here we report that dopamine signaling controls innate immune responses through a D1-like dopamine receptor, DOP-4, in Caenorhabditis elegans. Chlorpromazine inhibition of DOP-4 in the nervous system activates a microbicidal PMK-1/p38 mitogen-activated protein kinase signaling pathway that enhances host resistance against bacterial infections. The immune inhibitory function of dopamine originates in CEP neurons and requires active DOP-4 in downstream ASG neurons. Our findings indicate that dopamine signaling from the nervous system controls immunity in a cell-non-autonomous manner and identifies the dopaminergic system as a potential therapeutic target for not only infectious diseases but also a range of conditions that arise as a consequence of malfunctioning immune responses.


Subject(s)
Caenorhabditis elegans Proteins/genetics , Caenorhabditis elegans/physiology , Dopamine/physiology , Immunity, Innate , Receptors, Dopamine D2/genetics , Signal Transduction , Animals , Caenorhabditis elegans/genetics , Caenorhabditis elegans Proteins/metabolism , Chlorpromazine/pharmacology , Dopamine Antagonists/pharmacology , Neural Inhibition , Neurons/physiology , Receptors, Dopamine D2/metabolism
7.
J Biol Chem ; 291(19): 10046-57, 2016 May 06.
Article in English | MEDLINE | ID: mdl-26957546

ABSTRACT

The partially de-N-acetylated poly-ß-1,6-N-acetyl-d-glucosamine (dPNAG) polymer serves as an intercellular biofilm adhesin that plays an essential role for the development and maintenance of integrity of biofilms of diverse bacterial species. Translocation of dPNAG across the bacterial outer membrane is mediated by a tetratricopeptide repeat-containing outer membrane protein, PgaA. To understand the molecular basis of dPNAG translocation, we determined the crystal structure of the C-terminal transmembrane domain of PgaA (residues 513-807). The structure reveals that PgaA forms a 16-strand transmembrane ß-barrel, closed by four loops on the extracellular surface. Half of the interior surface of the barrel that lies parallel to the translocation pathway is electronegative, suggesting that the corresponding negatively charged residues may assist the secretion of the positively charged dPNAG polymer. In vivo complementation assays in a pgaA deletion bacterial strain showed that a cluster of negatively charged residues proximal to the periplasm is necessary for biofilm formation. Biochemical analyses further revealed that the tetratricopeptide repeat domain of PgaA binds directly to the N-deacetylase PgaB and is critical for biofilm formation. Our studies support a model in which the positively charged PgaB-bound dPNAG polymer is delivered to PgaA through the PgaA-PgaB interaction and is further targeted to the ß-barrel lumen of PgaA potentially via a charge complementarity mechanism, thus priming the translocation of dPNAG across the bacterial outer membrane.


Subject(s)
Amidohydrolases/chemistry , Bacterial Outer Membrane Proteins/chemistry , Bacterial Physiological Phenomena , Biofilms/growth & development , Cell Membrane/metabolism , Escherichia coli Proteins/chemistry , Escherichia coli/metabolism , Polysaccharides, Bacterial/metabolism , Acetylation , Amidohydrolases/metabolism , Bacterial Outer Membrane Proteins/metabolism , Crystallography, X-Ray , Escherichia coli/growth & development , Escherichia coli Proteins/metabolism , Immunoblotting , Polymers/chemistry , Protein Conformation
8.
J Biol Chem ; 290(49): 29231-9, 2015 Dec 04.
Article in English | MEDLINE | ID: mdl-26475858

ABSTRACT

Increasing evidence indicates that immune responses to microbial infections may contribute to neurodegenerative diseases. Here, we show that Pseudomonas aeruginosa infection of Caenorhabditis elegans causes a number of neural changes that are hallmarks of neurodegeneration. Using an unbiased genetic screen to identify genes involved in the control of P. aeruginosa-induced neurodegeneration, we identified mes-1, which encodes a receptor tyrosine kinase-like protein that is required for unequal cell divisions in the early embryonic germ line. We showed that sterile but not fertile mes-1 animals were resistant to neurodegeneration induced by P. aeruginosa infection. Similar results were observed using animals carrying a mutation in the maternal effect gene pgl-1, which is required for postembryonic germ line development, and the germ line-deficient strains glp-1 and glp-4. Additional studies indicated that the FOXO transcription factor DAF-16 is required for resistance to P. aeruginosa-induced neurodegeneration in germ line-deficient strains. Thus, our results demonstrate that P. aeruginosa infection results in neurodegeneration phenotypes in C. elegans that are controlled by the germ line in a cell-nonautonomous manner.


Subject(s)
Caenorhabditis elegans Proteins/genetics , Caenorhabditis elegans/genetics , Caenorhabditis elegans/microbiology , Neurodegenerative Diseases/microbiology , Pseudomonas Infections/genetics , Animals , Caenorhabditis elegans Proteins/metabolism , Chemotaxis , Disease Models, Animal , Green Fluorescent Proteins/metabolism , Host-Pathogen Interactions , Immunity, Innate , Mutation , Neurodegenerative Diseases/genetics , Osmotic Pressure , Phenotype , Pseudomonas aeruginosa , RNA Interference
9.
mBio ; 5(4)2014 Aug 12.
Article in English | MEDLINE | ID: mdl-25118236

ABSTRACT

UNLABELLED: The purpose of this study was to take advantage of the nematode Caenorhabditis elegans to perform a whole-animal chemical screen to identify potential immune activators that may confer protection against bacterial infections. We identified 45 marketed drugs, out of 1,120 studied compounds, that are capable of activating a conserved p38/PMK-1 mitogen-activated protein kinase pathway required for innate immunity. One of these drugs, the last-resort antibiotic colistin, protected against infections by the Gram-negative pathogens Yersinia pestis and Pseudomonas aeruginosa but not by the Gram-positive pathogens Enterococcus faecalis and Staphylococcus aureus. Protection was independent of the antibacterial activity of colistin, since the drug was administered prophylactically prior to the infections and it was also effective against antibiotic-resistant bacteria. Immune activation by colistin is mediated not only by the p38/PMK-1 pathway but also by the conserved FOXO transcription factor DAF-16 and the transcription factor SKN-1. Furthermore, p38/PMK-1 was found to be required in the intestine for immune activation by colistin. Enhanced p38/PMK-1-mediated immune responses by colistin did not reduce the bacterial burden, indicating that the pathway plays a role in the development of host tolerance to infections by Gram-negative bacteria. IMPORTANCE: The innate immune system represents the front line of our defenses against invading microorganisms. Given the ever-increasing resistance to antibiotics developed by bacterial pathogens, the possibility of boosting immune defenses represents an interesting, complementary approach to conventional antibiotic treatments. Here we report that the antibiotic colistin can protect against infections by a mechanism that is independent of its microbicidal activity. Prophylactic treatment with colistin activates a conserved p38/PMK-1 pathway in the intestine that helps the host better tolerate a bacterial infection. Since p38/PMK-1-mediated immune responses appear to be conserved from plants to mammals, colistin may also activate immunity in higher organisms, including humans. Antibiotics with immunomodulatory properties have the potential of improving the long-term outcome of patients with chronic infectious diseases.


Subject(s)
Caenorhabditis elegans/immunology , Caenorhabditis elegans/microbiology , Colistin/immunology , Colistin/pharmacology , Drug Evaluation, Preclinical/methods , Immunity, Innate , Mitogen-Activated Protein Kinases/metabolism , Animals , Bacterial Infections/immunology , Bacterial Infections/prevention & control , Caenorhabditis elegans/drug effects , Caenorhabditis elegans/metabolism , Enterococcus faecalis/drug effects , Enterococcus faecalis/immunology , Immunomodulation , Microarray Analysis , Models, Animal , Pseudomonas aeruginosa/drug effects , Pseudomonas aeruginosa/immunology , Staphylococcus aureus/drug effects , Staphylococcus aureus/immunology , Yersinia pestis/drug effects , Yersinia pestis/immunology , p38 Mitogen-Activated Protein Kinases/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL